10-K Filing

CENCORA, INC. CIK: 1140859 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001140859-21-000058`
Period End Date	20210930
Filing Date	20211123
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	abc-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 70 Cash Flow Statement 140 Stockholders Equity 38 Comprehensive Income 21

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Allowances for returns and credit losses	`AccountsReceivableAllowanceForReturnsAndCreditLossCurrent`	$1.36B	USD	Point-in-time
Allowances for returns and credit losses	`AccountsReceivableAllowanceForReturnsAndCreditLossCurrent`	$1.42B	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.60B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.55B	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Accounts receivable, less allowances for returns and credit losses: 2021 $1,356,684; 2020 $1,417,308	`AccountsReceivableNetCurrent`	$13.85B	USD	Point-in-time
Accounts receivable, less allowances for returns and credit losses: 2021 $1,356,684; 2020 $1,417,308	`AccountsReceivableNetCurrent`	$18.17B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	290.72M	shares	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	287.79M	shares	Point-in-time
Inventories	`InventoryNet`	$12.59B	USD	Point-in-time
Inventories	`InventoryNet`	$15.37B	USD	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	204.23M	shares	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	208.09M	shares	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	83.56M	shares	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	82.63M	shares	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.27B	USD	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.34B	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$221.88M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$488.43M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$189.30M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$853.60M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$372.91M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.06B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.80B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.16B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.48B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Goodwill	`Goodwill`	$9.03B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$5.26B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$1.89B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$290.79M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$361.64M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$779.85M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.79B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$57.34B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$44.27B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$38.01B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.71B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$1.65B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$2.86B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$300.21M	USD	Point-in-time
Short-term debt	`DebtCurrent`	$501.26M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$192.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$41.36B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.85B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.62B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$6.38B	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$284.85M	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$281.07M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.69B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$686.49M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.08B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$472.86M	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$6.20B	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$5.96B	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value authorized, issued, and outstanding: 2021 600,000,000 shares, 290,722,533 shares and 208,089,298 shares; 2020 600,000,000 shares, 287,790,479 shares and 204,226,465 shares	`CommonStockValue`	$2.88M	USD	Point-in-time
Common stock, $0.01 par value authorized, issued, and outstanding: 2021 600,000,000 shares, 290,722,533 shares and 208,089,298 shares; 2020 600,000,000 shares, 287,790,479 shares and 204,226,465 shares	`CommonStockValue`	$2.91M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.47B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.08B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$518.34M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.67B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-445.44M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-108.83M	USD	Point-in-time
Treasury stock, at cost: 2021 82,633,235 shares; 2020 83,564,014 shares	`TreasuryStockValue`	$6.51B	USD	Point-in-time
Treasury stock, at cost: 2021 82,633,235 shares; 2020 83,564,014 shares	`TreasuryStockValue`	$6.47B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' equity (deficit)	`StockholdersEquity`	$223.35M	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' equity (deficit)	`StockholdersEquity`	$-1.02B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$179.29M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$361.06M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.05B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$584.41M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$44.27B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$57.34B	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$213.99B	USD	Annual
Revenue	`Revenues`	$189.89B	USD	Annual
Revenue	`Revenues`	$179.59B	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$174.45B	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$207.05B	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$184.70B	USD	Annual
Gross profit	`GrossProfit`	$6.94B	USD	Annual
Gross profit	`GrossProfit`	$5.19B	USD	Annual
Gross profit	`GrossProfit`	$5.14B	USD	Annual
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$2.66B	USD	Annual
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$3.59B	USD	Annual
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$2.77B	USD	Annual
Depreciation	`DepreciationNonproduction`	$280.19M	USD	Annual
Depreciation	`DepreciationNonproduction`	$294.96M	USD	Annual
Depreciation	`DepreciationNonproduction`	$326.82M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$167.44M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$110.88M	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$178.35M	USD	Annual
Employee severance, litigation, and other	`RestructuringCharges`	$330.47M	USD	Annual
Employee severance, litigation, and other	`RestructuringCharges`	$471.91M	USD	Annual
Employee severance, litigation, and other	`RestructuringCharges`	$6.81B	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$6.37M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$6.40M	USD	Point-in-time
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Impairment of assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$11.32M	USD	Annual
Impairment of assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$570.00M	USD	Annual
Impairment of assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$138.00M	USD	1 Quarter
Impairment of assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$570.00M	USD	1 Quarter
Impairment of assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$361.65M	USD	Annual
Impairment of assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$223.70M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$1.11B	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$2.35B	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$-5.14B	USD	Annual
Other income	`NonoperatingIncomeExpense`	$12.95M	USD	Annual
Other income	`NonoperatingIncomeExpense`	$1.58M	USD	Annual
Other income	`NonoperatingIncomeExpense`	$41.74M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-157.77M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-174.07M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-137.88M	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$967.11M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.29B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.22B	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$112.97M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.89B	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$677.25M	USD	Annual
Net income (loss)	`ProfitLoss`	$854.13M	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.16M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.23M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.68M	USD	Annual
Net income (loss) attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$855.37M	USD	Annual
Net income (loss) attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$-3.41B	USD	Annual
Net income (loss) attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.54B	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$4.07	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$-16.65	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$7.48	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$7.39	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$4.04	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$-16.65	USD	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.92M	shares	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	210.16M	shares	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	204.78M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	211.84M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	204.78M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.47M	shares	Annual

Cash Flow Statement 140 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$854.13M	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$321.10M	USD	Annual
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$326.71M	USD	Annual
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$290.74M	USD	Annual
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$176.41M	USD	Annual
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$117.27M	USD	Annual
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$188.07M	USD	Annual
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$12.10M	USD	Annual
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$25.20M	USD	Annual
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$11.91M	USD	Annual
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$334.87M	USD	Annual
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.54B	USD	Annual
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$28.54M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$74.41M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$99.59M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$58.87M	USD	Annual
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$7.42M	USD	Annual
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$-203.03M	USD	Annual
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$-22.54M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$361.65M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$570.00M	USD	Annual
Impairment of assets	`AssetImpairmentCharges`	$31.70M	USD	Annual
Gain on sale of equity investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Gain on sale of equity investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Gain on sale of equity investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$13.69M	USD	Annual
Gain on remeasurement of equity investment	`EquityInvestmentRemeasurementGainLoss`	$64.72M	USD	Annual
Gain on remeasurement of equity investment	`EquityInvestmentRemeasurementGainLoss`	-	USD	Annual
Gain on remeasurement of equity investment	`EquityInvestmentRemeasurementGainLoss`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$23.19M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-29.36M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$3.04M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.63B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$930.08M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.24B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.62B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.12B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$167.99M	USD	Annual
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$2.83M	USD	Annual
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-266.55M	USD	Annual
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$482.57M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.05M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-141.06M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.90M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.30B	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.56B	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.05B	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-3.29M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-13.35M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-54.88M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$372.08M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$239.69M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$524.02M	USD	Annual
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$6.20B	USD	Annual
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	-	USD	Annual
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$-236.99M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-46.83M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-123.24M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.57M	USD	Annual
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$2.67B	USD	Annual
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$2.34B	USD	Annual
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$2.21B	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$310.22M	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$438.22M	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$369.68M	USD	Annual
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$63.95M	USD	Annual
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.56B	USD	Annual
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$56.08M	USD	Annual
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$162.62M	USD	Annual
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Proceeds on sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$14.44M	USD	Annual
Proceeds on sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$36.36M	USD	Annual
Proceeds on sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.29M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.95M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-7.86M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-9.52M	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-6.14B	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-379.87M	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-375.83M	USD	Annual
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$506.95M	USD	Annual
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$3.17B	USD	Annual
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$599.48M	USD	Annual
Senior notes and other loan repayments	`RepaymentsOfLongTermDebt`	$835.31M	USD	Annual
Senior notes and other loan repayments	`RepaymentsOfLongTermDebt`	$598.45M	USD	Annual
Senior notes and other loan repayments	`RepaymentsOfLongTermDebt`	$510.86M	USD	Annual
Borrowings under revolving and securitization credit facilities	`ProceedsFromLongTermLinesOfCredit`	$4.97B	USD	Annual
Borrowings under revolving and securitization credit facilities	`ProceedsFromLongTermLinesOfCredit`	$640.13M	USD	Annual
Borrowings under revolving and securitization credit facilities	`ProceedsFromLongTermLinesOfCredit`	$116.95M	USD	Annual
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$769.28M	USD	Annual
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$149.98M	USD	Annual
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$5.08B	USD	Annual
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	$21.45M	USD	Annual
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	-	USD	Annual
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	-	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$82.15M	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$420.45M	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$674.03M	USD	Annual
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$159.53M	USD	Annual
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$198.75M	USD	Annual
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$76.23M	USD	Annual
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$366.65M	USD	Annual
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$338.97M	USD	Annual
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$343.58M	USD	Annual
Profarma retail equity offering	`ProceedsFromIssuanceOfCommonStock`	$66.36M	USD	Annual
Profarma retail equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Profarma retail equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.99M	USD	Annual
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$9.79M	USD	Annual
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$23.55M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.68M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$9.89M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.24M	USD	Annual
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$1.95B	USD	Annual
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-603.62M	USD	Annual
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-1.09B	USD	Annual
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Annual
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-3.73M	USD	Annual
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Annual
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAndDisposalGroupIncludingDiscontinueOperation`	$-1.53B	USD	Annual
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAndDisposalGroupIncludingDiscontinueOperation`	$1.22B	USD	Annual
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAndDisposalGroupIncludingDiscontinueOperation`	$881.68M	USD	Annual
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`DisposalGroupIncludingDiscontinuedOperationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	-	USD	Annual
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`DisposalGroupIncludingDiscontinuedOperationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.75M	USD	Annual
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE	`DisposalGroupIncludingDiscontinuedOperationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	-	USD	Annual
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$881.68M	USD	Annual
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.22B	USD	Annual
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.53B	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.07B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.07B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Cash dividends (usd per share)	`CommonStockDividendsPerShareCashPaid`	$1.66	USD	Annual
Cash dividends (usd per share)	`CommonStockDividendsPerShareCashPaid`	$1.60	USD	Annual
Cash dividends (usd per share)	`CommonStockDividendsPerShareCashPaid`	$1.76	USD	Annual
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.05B	USD	Point-in-time
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Balance, beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$584.41M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$854.13M	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-334.51M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-33.23M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-8.95M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$338.97M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$343.58M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$366.65M	USD	Annual
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$76.23M	USD	Annual
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$159.53M	USD	Annual
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$198.75M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$74.41M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$58.87M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$99.59M	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$405.69M	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$664.80M	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$82.15M	USD	Annual
Profarma retail equity offering	`StockIssuedDuringPeriodValueNewIssues`	$66.36M	USD	Annual
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$23.55M	USD	Annual
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$5.99M	USD	Annual
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$9.79M	USD	Annual
Equity consideration issued for acquisition of Alliance Healthcare (Note 2)	`StockIssuedDuringPeriodValueAcquisitions`	$235.14M	USD	Annual
Acquisition of Alliance Healthcare (Note 2)	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$178.26M	USD	Annual
Other	`StockholdersEquityOther`	$718.00K	USD	Annual
Other	`StockholdersEquityOther`	$1.36M	USD	Annual
Other	`StockholdersEquityOther`	$422.00K	USD	Annual
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.05B	USD	Point-in-time
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Balance, end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$584.41M	USD	Point-in-time

Comprehensive Income 21 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$854.13M	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.40B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.54B	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-334.52M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-32.96M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.87M	USD	Annual
Other, net	`OtherComprehensiveIncomeOtherNetOfTax`	$10.00K	USD	Annual
Other, net	`OtherComprehensiveIncomeOtherNetOfTax`	$-1.07M	USD	Annual
Other, net	`OtherComprehensiveIncomeOtherNetOfTax`	$-271.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-334.51M	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-33.23M	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-8.95M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$820.91M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.21B	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.41B	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.78M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-2.92M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.75M	USD	Annual
Comprehensive income (loss) income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$822.65M	USD	Annual
Comprehensive income (loss) income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$-3.41B	USD	Annual
Comprehensive income (loss) income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$1.20B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.